Vaccines
18 December 2017
Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer12 December 2017
Aduro Biotech Provides Update on CRS-207 Programs11 December 2017
Altimmune Submits Investigational New Drug Application for NasoShield in Preparation for its Phase 1 Trial7 December 2017
Aptinyx Granted Fast Track Designation, Initiates Phase 1 for Second Clinical Candidate, NYX-783, in Post-Traumatic Stress Disorder5 December 2017
Immunovaccine Announces Positive Clinical Data from Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer4 December 2017
Sanofi ends development of Clostridium difficile vaccine29 November 2017
Sanofi updates information on dengue vaccine13 November 2017
NousCom’s Neoantigen-based Vaccine Synergizes With NKTR-214 to Cure Established Tumors in Preclinical Model12 November 2017
Argos Therapeutics Provides Update on Immunology Data from the Phase 3 ADAPT Trial Presented at the SITC 2017 Annual Meeting12 November 2017
Dynavax Announces FDA Approval of HEPLISAV-B(TM) for Prevention of Hepatitis B in Adults10 November 2017
Inovio Pharmaceuticals Presents Immuno-Oncology Advancements At Society for Immunotherapy of Cancer Conference9 November 2017
Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine8 November 2017
Batu Biologics Receives FDA Clearance for First Multi-Pronged Immunotherapy Targeting the Blood Vessels that Feed Cancer8 November 2017
Pique Therapeutics Announces Positive Results in Phase 2 Clinical Trial of Lead Immunotherapy for Non-Small Cell Lung CancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports